COVID-19: Vaccines and Therapeutics
This is a set of resources to help hospitals and health systems reassure staff, patients and communities of COVID-19 vaccines’ safety and effectiveness. It includes messaging for many important audiences, whether organizational (stakeholders inside hospitals or health systems) or public-facing (…
The American Medical Association announced Current Procedural Terminology codes for reporting on medical claims two COVID-19 vaccines and their administration to patients by dose.
Pfizer Inc. announced that BNT162b2, its mRNA-based vaccine candidate, is more than 90% effective in preventing COVID-19, based on early data that has yet to be peer-reviewed.
German biotech firm CureVac N.V. announced interim data from its ongoing Phase 1 dose-escalation study evaluating its CVnCoV SARS-CoV-2 vaccine candidate for safety, reactogenicity and immunogenicity.
The Centers for Medicare & Medicaid Services announced an interim final rule establishing additional Medicare hospital payment to support Medicare beneficiaries’ access to COVID-19 vaccines and new treatments when they become available.
A COVID-19 vaccine is likely coming soon. Whether it’s next month, at the end of the year or in early 2021, many scientific experts believe we will have one or more safe and effective vaccines to combat the deadly virus.
State-licensed pharmacists and state-authorized pharmacy interns under their supervision may administer COVID-19 vaccines and tests authorized or licensed by the Food and Drug Administration, subject to certain requirements, the Department of Health and Human Services said in guidance.
Moderna Inc., announced the completion of enrollment for its COVID-19 vaccine phase 3 trial.
The Department of Health and Human Services announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to long-term care facility residents.
The Centers for Disease Control and Prevention added vaccine information to its COVID-19 webpage.